[Retracted] A Systematic Review and Meta-Analysis of Therapeutic Efficacy and Safety of Alirocumab and Evolocumab on Familial Hypercholesterolemia

Figure 4

Forest plots depicting the effect of PCSK9 monoclonal antibody on FH; (a) on LDL-C; (b) on HDL-C; (c) on Apo-A1; (d) on Apo-B; (e) on non-HDL-C; (f) on TC; (g) on TG; (h) on Lp(a).

(a)

(b)

(c)

(d)

(e)

(f)

(g)

(h)